Back to search
FDAFDA · Food and drugs·Recall number D-0833-2016

Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.

Published April 27, 2016 · Recall initiated: March 24, 2016

Summary

FDA records drug Class III recall D-0833-2016, published April 27, 2016 and initiated March 24, 2016. Recalling firm: AbbVie Inc.; Status: Terminated; Reported quantity: 307 bottles; Lot: Lot #1055586, Exp.1/21/ 2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Content Uniformity Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if ZEMPLAR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZEMPLAR
Manufacturer
AbbVie Inc.
Distributor
Nationwide
UPC
0300749036309
Lot
Lot #1055586, Exp.1/21/ 2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30. recalled?

Yes. FDA published recall D-0833-2016 on April 27, 2016. Reported hazard: Failed Content Uniformity Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZEMPLAR. UPC: 0300749036309.